Cargando…

Updates on Anticancer Therapy-Mediated Vascular Toxicity and New Horizons in Therapeutic Strategies

Vascular toxicity is a frequent adverse effect of current anticancer chemotherapies and often results from endothelial dysfunction. Vascular endothelial growth factor inhibitors (VEGFi), anthracyclines, plant alkaloids, alkylating agents, antimetabolites, and radiation therapy evoke vascular toxicit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hsu, Po-Yen, Mammadova, Aynura, Benkirane-Jessel, Nadia, Désaubry, Laurent, Nebigil, Canan G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353082/ https://www.ncbi.nlm.nih.gov/pubmed/34386529 http://dx.doi.org/10.3389/fcvm.2021.694711

Ejemplares similares

Targeting GPCRs Against Cardiotoxicity Induced by Anticancer Treatments
por: Audebrand, Anais, et al.
Publicado: (2020)

Flavaglines as natural products targeting eIF4A and prohibitins: From traditional Chinese medicine to antiviral activity against coronaviruses
por: Nebigil, Canan G., et al.
Publicado: (2020)

Updates in Anthracycline-Mediated Cardiotoxicity
por: Nebigil, Canan G., et al.
Publicado: (2018)

Prohibitin Ligands in Cell Death and Survival: Mode of Action and Therapeutic Potential
por: Thuaud, Frédéric, et al.
Publicado: (2013)

Discovery of GPCR ligands for probing signal transduction pathways
por: Brogi, Simone, et al.
Publicado: (2014)

Prokineticin Is a New Linker between Obesity and Cardiovascular Diseases
por: Nebigil, Canan G.
Publicado: (2017)

Screening of the small molecule library of Meinox enables the identification of anticancer compounds in pathologically distinct cancers
por: MAMMADOVA, Aynura, et al.
Publicado: (2021)

FL3, a Synthetic Flavagline and Ligand of Prohibitins, Protects Cardiomyocytes via STAT3 from Doxorubicin Toxicity
por: Qureshi, Rehana, et al.
Publicado: (2015)

The flavagline FL3 interferes with the association of Annexin A2 with the eIF4F initiation complex and transiently stimulates the translation of annexin A2 mRNA
por: Grindheim, Ann Kari, et al.
Publicado: (2023)

SFPH proteins as therapeutic targets for a myriad of diseases
por: Wang, Dong, et al.
Publicado: (2020)

Prokineticin Receptor-1 Signaling Inhibits Dose- and Time-Dependent Anthracycline-Induced Cardiovascular Toxicity Via Myocardial and Vascular Protection
por: Gasser, Adeline, et al.
Publicado: (2019)

Editorial: HF2Cancer: Exploring bidirectional interaction between cardiovascular diseases and cancer
por: Nebigil, Canan G., et al.
Publicado: (2023)

Editorial: Emerging Challenges of Cardiovascular and Metabolic Dysfunctions in Cardio-Oncology: From Bench to Bedside
por: Nebigil, Canan G., et al.
Publicado: (2020)

Flavagline synthetic derivative induces senescence in glioblastoma cancer cells without being toxic to healthy astrocytes
por: Harmouch, Ezeddine, et al.
Publicado: (2020)

Flavaglines Alleviate Doxorubicin Cardiotoxicity: Implication of Hsp27
por: Bernard, Yohann, et al.
Publicado: (2011)

Therapeutic Potential of Targeting Prokineticin Receptors in Diseases
por: Vincenzi, Martina, et al.
Publicado: (2023)

Evidence for reciprocal network interactions between injured hearts and cancer
por: Guler, Melisa N., et al.
Publicado: (2022)

Cardiotoxicity of Anticancer Therapeutics
por: Dong, Jerry, et al.
Publicado: (2018)

Discovery and Cardioprotective Effects of the First Non-Peptide Agonists of the G Protein-Coupled Prokineticin Receptor-1
por: Gasser, Adeline, et al.
Publicado: (2015)

Epigenetic Mechanisms Involved in the Cardiovascular Toxicity of Anticancer Drugs
por: Papazoglou, Panagiota, et al.
Publicado: (2021)

Implication of Toll/IL-1 receptor domain containing adapters in Porphyromonas gingivalis-induced inflammation
por: Bugueno, Isaac M, et al.
Publicado: (2021)

Cancer wars: natural products strike back
por: Basmadjian, Christine, et al.
Publicado: (2014)

Editorial: New horizons in the management of patients with atrial fibrillation: Interactions with the gastrointestinal system
por: Rivera-Caravaca, José Miguel, et al.
Publicado: (2022)

An Updated Review on the Psychoactive, Toxic and Anticancer Properties of Kava
por: Soares, Rita B., et al.
Publicado: (2022)

AMPK: Potential Therapeutic Target for Vascular Calcification
por: Lu, Yi, et al.
Publicado: (2021)

A therapeutic oxygen carrier isolated from Arenicola marina decreased P. gingivalis induced inflammation and tissue destruction
por: Batool, Fareeha, et al.
Publicado: (2020)

Prokineticin receptor-1-dependent paracrine and autocrine pathways control cardiac tcf21(+) fibroblast progenitor cell transformation into adipocytes and vascular cells
por: Qureshi, Rehana, et al.
Publicado: (2017)

Transcatheter Aortic Valve Implantation: All Transfemoral? Update on Peripheral Vascular Access and Closure
por: Perrin, Nils, et al.
Publicado: (2021)

Editorial: Transcatheter Aortic Valve Implantation: All Transfemoral? Update on Vascular Acccess and Closure
por: Cerillo, Alfredo Giuseppe, et al.
Publicado: (2022)

Mitochondrial Dynamics: Pathogenesis and Therapeutic Targets of Vascular Diseases
por: Luan, Yi, et al.
Publicado: (2021)

Thrombosis and Vascular Inflammation in Diabetes: Mechanisms and Potential Therapeutic Targets
por: Pechlivani, Nikoletta, et al.
Publicado: (2018)

Updated Insights on Cardiac and Vascular Risks of Proton Pump Inhibitors: A Real-World Pharmacovigilance Study
por: Zhai, Yinghong, et al.
Publicado: (2022)

Krüppel-Like Factors in Vascular Inflammation: Mechanistic Insights and Therapeutic Potential
por: Sweet, David R., et al.
Publicado: (2018)

Cell Type Influences Local Delivery of Biomolecules from a Bioinspired Apatite Drug Delivery System
por: Alhamdi, Jumana, et al.
Publicado: (2018)

Nano-Structured Ridged Micro-Filaments (≥100 µm Diameter) Produced Using a Single Step Strategy for Improved Bone Cell Adhesion and Proliferation in Textile Scaffolds
por: Behary, Nemeshwaree, et al.
Publicado: (2022)

Unresolved Issues in RNA Therapeutics in Vascular Diseases With a Focus on Aneurysm Disease
por: Schellinger, Isabel N., et al.
Publicado: (2021)

New Therapeutic Horizons for Graves’ Hyperthyroidism
por: Lane, Laura C, et al.
Publicado: (2020)

Multiple Sclerosis: Therapeutic Strategies on the Horizon
por: Talanki Manjunatha, Ramya, et al.
Publicado: (2022)

Correction: Nguyen T.L., et al. Role of Prokineticin Receptor-1 in Epicardial Progenitor Cells. J. Dev. Biol. 2013, 1, 20–31
por: Nguyen, Thu Lan, et al.
Publicado: (2020)

Vascular Inflammation as a Therapeutic Target in COVID-19 “Long Haulers”: HIITing the Spot?
por: Christensen, Regitse Højgaard, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_o35avgmv38j8d001oobun8oqgi